prostate cancer
Conditions
Interventions
of 
prostate, 
Gleason
Gold Standard:Gold Standard: Pathology
Index test:PSMA/MR, 
the 
Sponsors
Chines PLA General Hospital
Eligibility
Sex/Gender
Male
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 45-75 years; 2. Patients with PSA higher than normal for 3 consecutive months; 3. Patients with a PS score of 0 or 1 in ECoG; 4. Patients whose life expectancy is more than 10 years; 5. Patients who can cooperate with and tolerate psma-pet / MR examination; 6. Men who can tolerate and cooperate with prostate puncture and choose radical prostatectomy as the main treatment for prostate cancer after diagnosis; 7. Patients with normal bone marrow function: neutrophil count >= 1.5 x 10^9 / L; platelet count >= 100 x 10^9 / L; hemoglobin >= 90 g / L; white blood cell count >= 3.6 x 10^9 / L; 8. Patients with normal coagulation function: INR <= 1.5, APTT <=1.5 times ULN, Pt < ULN + 4 seconds; 9. The ability of the subjects to understand and be willing to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with other known malignant tumors; 2. Patients with known HIV or AIDS related diseases, active or symptomatic viral hepatitis or chronic liver disease; 3. Patients with claustrophobia, etc., who can not tolerate psma-pet / MR examination during the course of treatment; 4. Patients who refuse or can't tolerate prostate puncture examination; 5. Patients who give up surgical treatment after diagnosis of prostate cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUV;DWI;prostate specific antigen, PSA;Gleason; | — |
Secondary
| Measure | Time frame |
|---|---|
| the location of the cancer; | — |
Countries
China
Contacts
Public ContactXu Baixuan
Chines PLA General Hospital
Outcome results
None listed